169 related articles for article (PubMed ID: 6108221)
21. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
Erbel R; Meyer J; Lambertz H; Schweizer P; Voelker W; Krebs W; Braun G; Effert S
Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326
[No Abstract] [Full Text] [Related]
22. Effects of prenalterol administered orally in patients with congestive heart failure.
Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
[TBL] [Abstract][Full Text] [Related]
23. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
Cardiologia; 1982; 27(1):33-43. PubMed ID: 6152732
[No Abstract] [Full Text] [Related]
24. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
[TBL] [Abstract][Full Text] [Related]
25. Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.
Pedersen T; Cleemann-Rasmussen K; Brynjolf I; Ording H; Nielsen PE; Rasmussen K
Eur J Clin Pharmacol; 1983; 25(3):287-92. PubMed ID: 6628515
[TBL] [Abstract][Full Text] [Related]
26. Acute haemodynamic effects of oral prenalterol in severe heart failure.
Petch MC; Wisbey C; Ormerod O; Scott C; Goodfellow RM
Br Heart J; 1984 Jul; 52(1):49-52. PubMed ID: 6146324
[TBL] [Abstract][Full Text] [Related]
27. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
Manders WT; Vatner SF; Braunwald E
J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
[TBL] [Abstract][Full Text] [Related]
28. Interaction in healthy volunteers between prenalterol, a selective beta 1-adrenoceptor agonist, and metoprolol or propranolol.
Rönn O; Johnsson G; Lundborg P
J Cardiovasc Pharmacol; 1981; 3(3):477-84. PubMed ID: 6168829
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
Hutton I; Tweddel AC; Bastian BC; Murray RG
Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
[No Abstract] [Full Text] [Related]
30. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
[TBL] [Abstract][Full Text] [Related]
31. Haemodynamic effects of prenalterol in patients on dialysis.
Lustenberger N
Acta Med Scand Suppl; 1982; 659():157-67. PubMed ID: 6127886
[TBL] [Abstract][Full Text] [Related]
32. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
Cucchini F; Baldi G; Bolognesi R; Ferrari R; Visioli O
J Cardiovasc Pharmacol; 1984; 6(5):822-8. PubMed ID: 6209486
[TBL] [Abstract][Full Text] [Related]
33. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
Wirtzfeld A; Klein G; Bibra HV; Sauer E
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
[TBL] [Abstract][Full Text] [Related]
34. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
[TBL] [Abstract][Full Text] [Related]
35. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
Kupper W; Schütt M; Bleifeld W
Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
[TBL] [Abstract][Full Text] [Related]
36. [Echocardiographic measurements of hemodynamic effects and pharmacokinetics of prenalterol (author's transl)].
Oltmanns D; Wester HA; Stein R
Z Kardiol; 1981 May; 70(5):394-8. PubMed ID: 6115520
[TBL] [Abstract][Full Text] [Related]
37. [Circulatory effects of prenalterol (a selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Ging LQ; Guazzi M
Cardiologia; 1982; 27(1):99-101. PubMed ID: 6152733
[No Abstract] [Full Text] [Related]
38. Immediate haemodynamic effects of prenalterol, a new adrenergic beta-1-receptor agonist, in healthy volunteers.
Svendsen TL; Hartling OJ; Trap-Jensen J
Eur J Clin Pharmacol; 1980 Oct; 18(3):219-23. PubMed ID: 6108219
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular effects of prenalterol (H133/22) in normal man.
Scott DH; Arthur GR; Boyes RN; Scott DB
Br J Clin Pharmacol; 1979 Apr; 7(4):365-70. PubMed ID: 36118
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
Acta Med Scand Suppl; 1982; 659():1-325. PubMed ID: 6127881
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
